Stay updated on Baricitinib in Adult Atopic Dermatitis Clinical Trial

Sign up to get notified when there's something new on the Baricitinib in Adult Atopic Dermatitis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Baricitinib in Adult Atopic Dermatitis Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    Locations were expanded to include numerous US states and Canadian provinces, with the HHS Vulnerability Disclosure entry removed; the revision is v3.3.3.
    Difference
    2%
    Check dated 2025-12-24T13:49:07.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    No Change Detected
  5. Check
    38 days ago
    Change Detected
    Summary
    Added a note that PubMed publications are automatically filled and may not all relate to the study, and updated the page revision to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-25T14:46:55.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    The government funding status notice at the top of the page was removed. This is an administrative change that does not affect the study details, eligibility criteria, or results.
    Difference
    0.2%
    Check dated 2025-11-18T07:29:21.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    No additions or deletions detected on the Study Details page for NCT03435081. The content and layout appear unchanged.
    Difference
    0.2%
    Check dated 2025-10-27T21:05:34.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    Major update: announces a version upgrade to v3.2.0 and publicly states funding-related operational notices, including that transactions may not be processed until appropriations are enacted.
    Difference
    1%
    Check dated 2025-10-06T08:26:52.000Z thumbnail image
  9. Check
    95 days ago
    Change Detected
    Summary
    Appended version label (v3.1.0) and removal of multiple drug-safety related sections, indicating content consolidation and reorganization rather than new substantive content.
    Difference
    0.2%
    Check dated 2025-09-29T05:14:03.000Z thumbnail image

Stay in the know with updates to Baricitinib in Adult Atopic Dermatitis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Baricitinib in Adult Atopic Dermatitis Clinical Trial page.